AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
253.35
+10.21 (4.20%)
At close: Jun 26, 2026, 4:00 PM EDT
252.98
-0.37 (-0.15%)
After-hours: Jun 26, 2026, 7:59 PM EDT
AbbVie Employees
AbbVie had 57,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 3.64% compared to the previous year.
Employees
57,000
Change (1Y)
2,000
Growth (1Y)
3.64%
Revenue / Employee
$1,102,088
Profits / Employee
$63,070
Market Cap
447.62B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57,000 | 2,000 | 3.64% |
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| Eli Lilly and Company | 50,000 |
ABBV News
- 4 hours ago - AbbVie says FDA approves Skyrizi for pediatric use in psoriatic disease - TheFly
- 4 hours ago - SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease - PRNewsWire
- 6 hours ago - Healthcare stocks have become a haven for investors ditching tech - Market Watch
- 13 hours ago - AbbVie to Host Second-Quarter 2026 Earnings Conference Call - PRNewsWire
- 2 days ago - AbbVie's $11 Billion Immunology Bet - Forbes
- 2 days ago - BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026 - PRNewsWire
- 3 days ago - AbbVie’s Allergan Aesthetics receives approval for Boey in Canada - TheFly
- 3 days ago - Apogee Therapeutics price target raised to $135 from $97 at RBC Capital - TheFly